Eikon Therapeutics, Inc. Common Stock

NASDAQ: EIKN · Healthcare · Biotechnology

PublicHQ Millbrae, CA · San MateoCIK 0001861123Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 46

v0.1 · 5/100 weight · pillars only

↑ workforce scale, market scale · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

484

Market cap

$37.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Eikon Therapeutics, Inc. Common Stock has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Radnostix, Inc.51D Nephros, Inc.75B+Stablecoin Development Corp.44D KALA BIO, Inc.31D

Neighbors

San Mateo →

Meta Platforms, Inc.$201.0B87A Gilead Sciences, Inc.$29.4B87A Robinhood Markets, Inc.$4.5B67B Equinix, Inc.$9.2B73B Electronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$052D

Key facts

CEORoger Perlmutter

SectorHealthcare

IndustryBiotechnology

HeadquartersMillbrae, CA

ExchangeNASDAQ: EIKN

Employees484

IPO date2026-02-05

Latest filings

8-K2026-06-10 8-K2026-06-01 10-Q2026-05-11 8-K2026-05-11 8-K2026-03-30 10-K2026-03-30 8-K2026-02-06

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.